Ridgeback Capital Investments
View More Recent Stories
-
Form SC 13G MYOMO INC Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G/A Karyopharm Therapeutics Filed by: Ridgeback Capital Investments L.P.
-
Form 3 Verastem, Inc. For: Jan 14 Filed by: Ridgeback Capital Investments Ltd.
-
Form SC 13G Verastem, Inc. Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G Spring Bank Pharmaceutic Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G/A Karyopharm Therapeutics Filed by: Ridgeback Capital Investments L.P.
-
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
-
Form SC 13G Corium International, Filed by: Ridgeback Capital Investments L.P.
-
Immutep Raises A$6.85m Through Institutional Placement
-
Form SC 13G/A Verastem, Inc. Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G Karyopharm Therapeutics Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G Verastem, Inc. Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G/A Celator Pharmaceuticals Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G/A ONCOSEC MEDICAL Inc Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G/A Cara Therapeutics, Inc. Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G/A Trillium Therapeutics Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G/A APPLIED GENETIC TECHNOLO Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G/A ONCOSEC MEDICAL Inc Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G ONCOSEC MEDICAL Inc Filed by: Ridgeback Capital Investments L.P.
-
Prima BioMed Announces A$15 Million Investment From US Healthcare Investor Ridgeback
-
Form SC 13G Cara Therapeutics, Inc. Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G Trillium Therapeutics Filed by: Ridgeback Capital Investments L.P.
-
Form SC 13G/A APPLIED GENETIC TECHNOLO Filed by: Ridgeback Capital Investments L.P.
-
Ridgeback Capital Investments L.P. Shows New 5.8% Stake in Geron Corp (GERN)
-
Ridgeback Capital Investments L.P. Raises Stake in Sangamo Biosciences, Inc. (SGMO) to 5.9%

